2012-10-10 09:32:35 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Humanetics Corporation - Product Pipeline Review - 2012" provides data on the Humanetics Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Humanetics Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Humanetics Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Humanetics Corporation - Brief Humanetics Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Humanetics Corporation human

therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Humanetics Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Humanetics Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468661_humanetics_corporation_product_pipeli ..


Reasons to buy

* Evaluate Humanetics Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Humanetics Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Humanetics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Humanetics Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Humanetics Corporation and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Humanetics Corporation Snapshot
Humanetics Corporation Overview
Key Information
Key Facts
Humanetics Corporation - Research and Development Overview
Key Therapeutic Areas
Humanetics Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Humanetics Corporation - Pipeline Products Glance
Humanetics Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Humanetics Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Humanetics Corporation - Drug Profiles
BIO-700
Product Description
Mechanism of Action
R&D Progress
BIO-800
Product Description
Mechanism of Action
R&D Progress
NIC5-15
Product Description
Mechanism of Action
R&D Progress
Humanetics Corporation - Pipeline Products by Route of Administration
Humanetics Corporation - Pipeline Products By Mechanism of Action
Humanetics Corporation - Recent Pipeline Updates
Humanetics Corporation - Dormant Projects
Humanetics Corporation - Locations And Subsidiaries
Head Office
Humanetics Corporation, Recent Developments
Humanetics Corporation- Press Release
Jun 27, 2012: Humanetics Announces Alzheimer's Disease Patent Issuance
Jul 12, 2009: Humanetics' Development Partner Mount Sinai Presents Phase IIA Preliminary Clinical Findings Of NIC5-15 At the Alzheimer's Association 2009
Financial Deals Landscape
Humanetics Corporation, Deals Summary
Humanetics Corporation, Pharmaceuticals & Healthcare, Deal Details
Licensing Agreements
Humanetics Enters Into Licensing Agreement For 7-Keto
Humanetics Enters Into Licensing Agreement With Henry Ford Health System For Two Post-Exposure Medical Radiation Countermeasures
Acquisition
Humanetics Sells Minnesota Applied Research Center To MAPS Applied Research Center
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Humanetics Corporation, Key Information
Humanetics Corporation, Key Facts
Humanetics Corporation - Pipeline by Indication, 2012
Humanetics Corporation - Pipeline by Stage of Development, 2012
Humanetics Corporation - Monotherapy Products in Pipeline, 2012
Humanetics Corporation - Phase II, 2012
Humanetics Corporation - Pre-Clinical, 2012
Humanetics Corporation - Pipeline By Route of Administration, 2012
Humanetics Corporation - Pipeline Products By Mechanism of Action, 2012
Humanetics Corporation - Recent Pipeline Updates, 2012
Humanetics Corporation - Dormant Developmental Projects,2012
Humanetics Corporation, Deals Summary
Humanetics Enters Into Licensing Agreement For 7-Keto
Humanetics Enters Into Licensing Agreement With Henry Ford Health System For Two Post-Exposure Medical Radiation Countermeasures
Humanetics Sells Minnesota Applied Research Center To MAPS Applied Research Center

List of Figures
Humanetics Corporation - Pipeline by Indication, 2012
Humanetics Corporation - Pipeline by Stage of Development, 2012
Humanetics Corporation - Monotherapy Products in Pipeline, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.